ZC3HAV1 Protein

📖 Wiki Page

protein1169 wordssynced 2026-04-02

ZC3HAV1 Protein (ZAP)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ZC3HAV1 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Location</td>
</tr>
<tr>
<td class="label">ZF1</td>
<td>Amino acids 51-74</td>
</tr>
<tr>
<td class="label">ZF2</td>
<td>Amino acids 130-153</td>
</tr>
<tr>
<td class="label">ZF3</td>
<td>Amino acids 181-204</td>
</tr>
<tr>
<td class="label">ZF4</td>
<td>Amino acids 233-256</td>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Amino Acids</td>
</tr>
<tr>
<td class="label">ZC3HAV1-L</td>
<td>707</td>
</tr>
<tr>
<td class="label">ZC3HAV1-S</td>
<td>652</td>
</tr>
<tr>
<td class="label">ZC3HAV1-L2</td>
<td>720</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">TRIM25</td>
<td>Ubiquitination</td>
</tr>
<tr>
<td class="label">RNA Exosome</td>
<td>Recruitment</td>
</tr>
<tr>
<td class="label">IRF3/IRF7</td>
<td>Cooperation</td>
</tr>
<tr>
<td class="label">PKR</td>
<td>Cross-talk</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">PABPC1</td>
<td>Antagonism</td>
</tr>
<tr>
<td class="label">MOV10</td>
<td>Cooperation</td>
</tr>
<tr>
<td class="label">Ars2</td>
<td>Regulation</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">[Neurons

...

ZC3HAV1 Protein (ZAP)

Introduction

Zinc Finger CCCH-Type Antiviral Protein 1 (ZC3HAV1), also known as ZAP, is a host restriction factor that plays a crucial role in the innate antiviral immune response. Originally identified for its ability to inhibit retroviral replication, ZC3HAV1 has emerged as an important player in antiviral defense against various viruses, including those potentially involved in neurodegenerative disease pathogenesis. Its function in targeting viral mRNAs for degradation and modulating immune responses makes it relevant to understanding the viral infection hypotheses in Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative disorders. [@zap]

Official Symbol: ZC3HAV1 (ZAP) [@structure] Official Full Name: Zinc Finger CCCH-Type Antiviral Protein 1 [@trim] Molecular Weight: ~82 kDa (isoform 1: 707 amino acids; isoform 2: 652 amino acids) [@zapa] Cellular Location: Cytoplasm (primary), Nucleus (some isoforms) [@zapb] Gene: ZC3HAV1 (Chromosome 7q34) UniProt ID: Q9UHF0

Overview

ZC3HAV1 is expressed in most cell types, including neurons, astrocytes, [microglia](/cell-types/microglia-neuroinflammation), and other cells in the central nervous system. It exists in multiple isoforms with different subcellular localizations and functional properties. The long isoform (ZC3HAV1-L) localizes primarily to the cytoplasm, while a shorter isoform (ZC3HAV1-S) can also localize to the nucleus.

As an antiviral restriction factor, ZC3HAV1:

Binds specifically to viral mRNAs
Recruits the RNA exosome for degradation
Inhibits viral protein translation
Can also act at earlier stages of the viral life cycle

Protein Structure

ZC3HAV1 contains several distinct structural domains:

CCCH-Type Zinc Finger Domains

The protein contains four CCCH-type zinc finger domains:

These domains recognize specific RNA sequences, particularly CpG-rich elements commonly found in viral genomes.

WWE Domain

Located at amino acids 400-500:

Mediates protein-protein interactions
Binds to poly(ADP-ribose) (PAR)
Involved in signaling complex formation

PARP-Like Domain (PARylation)

Located at amino acids 550-650:

Contains PARP homology region
May be catalytically inactive
Involved in protein interactions

Poly(A)-Nuclease Domain

Located at amino acids 660-707:

RNase activity in some isoforms
Contributes to RNA degradation
Essential for antiviral function

Isoforms

Molecular Function

Antiviral Mechanism

ZC3HAV1 employs multiple mechanisms to inhibit viral replication:

RNA Binding

CCCH fingers bind specific viral RNA sequences
Prefers CpG-rich sequences (unmethylated)
Recognizes viral genome elements and mRNAs

mRNA Degradation

Recruits the RNA exosome complex (EXOSC1-10)
3'-5' exonucleolytic degradation
Prevents translation of viral proteins

Translation Inhibition

Blocks ribosome loading
Prevents cap-dependent translation
Can also affect specific viral proteins

Genome Replication Block

Some evidence for direct replication interference
May affect reverse transcription (retroviruses)

RNA Recognition Specificity

ZC3HAV1 preferentially targets:

RNAs with high CpG content
Specific sequence motifs (CG-rich elements)
Viral genomes and transcripts

It can distinguish self from non-self RNA through:

Recognition of viral sequence patterns
Lack of host RNA modifications (e.g., N6-methyladenosine)
Context-dependent binding

Regulation

ZC3HAV1 activity is tightly regulated:

TRIM25-Mediated Regulation

TRIM25 E3 ubiquitin ligase ubiquitinates ZC3HAV1
Enhances its antiviral activity
Required for optimal function

Phosphorylation

Casein kinase 2 (CK2) phosphorylates ZC3HAV1
Enhances RNA binding
Increases antiviral activity

Interferon Induction

Type I and II interferons induce ZC3HAV1 expression
Part of ISG response
Amplifies antiviral state

Pathway Interactions

Innate Immune Signaling

Viral Counter-Defense

Role in Neurodegeneration

Alzheimer's Disease

ZC3HAV1 may play several roles in AD:

Viral Infection Hypothesis

Herpesviruses (HSV-1) implicated in AD
ZC3HAV1 responds to viral infections
May modulate [amyloid-beta](/proteins/amyloid-beta) response to infection

Neuroinflammation Modulation

Interferon-stimulated gene
Contributes to antiviral defense
May affect chronic inflammation

Potential Therapeutic Target

Enhancing ZC3HAV1 function
Antiviral strategies
Immunomodulation

Parkinson's Disease

In PD, ZC3HAV1 may contribute to:

Viral Susceptibility

Enteroviruses potentially linked to PD
ZC3HAV1 provides antiviral defense
Genetic variants may affect susceptibility

Immune Modulation

Interferon response in substantia nigra
Microglial activation
[Neuroinflammation](/mechanisms/neuroinflammation)

Amyotrophic Lateral Sclerosis

ZC3HAV1 in ALS:

Antiviral Defense

Potential viral involvement in ALS
ZC3HAV1 response to infections
May affect disease progression

RNA Metabolism

ALS involves RNA processing defects
ZC3HAV1 in RNA degradation
May intersect with ALS pathways

Other Neurodegenerative Conditions

Multiple Sclerosis: Viral triggers and immune response
Huntington's Disease: RNA metabolism alterations
Prion Diseases: Viral co-factors explored

Expression in the Brain

Therapeutic Potential

Enhancing Antiviral Defense

ZC3HAV1 Agonists

Interferon-based therapies
Small molecule activators
Gene therapy approaches

TRIM25 Modulators

Enhance ZC3HAV1 activation
Improve antiviral response

Challenges

Balancing antiviral immunity with inflammation
Cell-type specific targeting
[Blood-brain barrier](/entities/blood-brain-barrier) penetration
Potential for autoimmunity

Research Directions

Current research areas:

Viral Links

HSV-1 in AD
Enteroviruses in PD
Viral involvement in ALS

Mechanism Studies

RNA recognition specificity
Regulation of activity
Cell-type specific functions

Therapeutic Development

ZC3HAV1 modulators
Antiviral strategies
Immunomodulation

History

Key milestones in ZC3HAV1 research:

2002: ZAP identified as HIV-1 restriction factor
2005-2010: RNA degradation mechanism elucidated
2015-2020: Role in antiviral immunity expanded
2020s: Potential links to neurodegeneration explored

Background

The study of Zc3Hav1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[UniProt: ZC3HAV1](https://www.uniprot.org/uniprot/Q9UHF0)
[NCBI Gene: ZC3HAV1](https://www.ncbi.nlm.nih.gov/gene/9204)
[Human Protein Atlas: ZC3HAV1](https://www.proteinatlas.org/gene/ZC3HAV1)

References

[Unknown, - ZAP antiviral mechanism and RNA binding (n.d.)](https://pubmed.ncbi.nlm.nih.gov/14697608/)

[Unknown, - Structure of CCCH-type zinc fingers (n.d.)](https://pubmed.ncbi.nlm.nih.gov/24812041/)

[Unknown, - TRIM25 regulation of ZAP (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25620057/)

[Unknown, - ZAP in antiviral immunity (n.d.)](https://pubmed.ncbi.nlm.nih.gov/28714947/)

[Unknown, - ZAP and RNA exosome recruitment (n.d.)](https://pubmed.ncbi.nlm.nih.gov/31234567/)

📖 View canonical wiki page →

ZC3HAV1 Protein

ZC3HAV1 Protein (ZAP)

ZC3HAV1 Protein (ZAP)

Introduction

Overview

Protein Structure

CCCH-Type Zinc Finger Domains

WWE Domain

PARP-Like Domain (PARylation)

Poly(A)-Nuclease Domain

Isoforms

Molecular Function

Antiviral Mechanism

RNA Recognition Specificity

Regulation

Pathway Interactions

Innate Immune Signaling

Viral Counter-Defense

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Other Neurodegenerative Conditions

Expression in the Brain

Therapeutic Potential

Enhancing Antiviral Defense

Challenges

Research Directions

History

Background

See Also

External Links

References